Kercheville Advisors’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-114,897
| Closed | -$3.41M | – | 95 |
|
|
2023
Q4 | $3.41M | Sell |
114,897
-1,680
| -1% | -$49.8K | 1.91% | 19 |
|
|
2023
Q3 | $1.85M | Sell |
116,577
-59,463
| -34% | -$944K | 1.17% | 27 |
|
|
2023
Q2 | $3.32M | Sell |
176,040
-76,512
| -30% | -$1.44M | 2.01% | 20 |
|
|
2023
Q1 | $970K | Sell |
252,552
-26,075
| -9% | -$100K | 0.66% | 33 |
|
|
2022
Q4 | $1.38M | Buy |
278,627
+40,325
| +17% | +$200K | 0.95% | 28 |
|
|
2022
Q3 | $1.14M | Buy |
238,302
+1,100
| +0.5% | +$5.26K | 1.16% | 24 |
|
|
2022
Q2 | $1.07M | Buy |
237,202
+10,600
| +5% | +$47.7K | 0.7% | 32 |
|
|
2022
Q1 | $1.08M | Buy |
226,602
+19,950
| +10% | +$95K | 0.51% | 42 |
|
|
2021
Q4 | $1.53M | Buy |
206,652
+16,950
| +9% | +$126K | 0.67% | 34 |
|
|
2021
Q3 | $1.08M | Sell |
189,702
-7,300
| -4% | -$41.4K | 0.51% | 45 |
|
|
2021
Q2 | $1.3M | Buy |
197,002
+3,247
| +2% | +$21.4K | 0.6% | 47 |
|
|
2021
Q1 | $1.56M | Sell |
193,755
-50,666
| -21% | -$407K | 0.78% | 38 |
|
|
2020
Q4 | $1.56M | Buy |
+244,421
| New | +$1.56M | 0.85% | 33 |
|